Zilu Chen
- Nephrology top 5%
-
- Fibroblast Growth Factor Research 3
- Epigenetics and DNA Methylation 3
- RNA Interference and Gene Delivery 2
-
- Cancer-related molecular mechanisms research 4
-
- Ferroptosis and cancer prognosis 3
-
- Head and Neck Cancer Studies 3
-
- Cancer Mechanisms and Therapy 2
-
- Intestinal and Peritoneal Adhesions 2
- Journals
- ACS Nano (1 paper)Scientific Reports (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zilu Chen
23 papers receiving 770 citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Nephrology 128
- Molecular Biology 562
- Immunology 172
- Cancer Research 113
- Pulmonary and Respiratory Medicine 143
Countries citing papers authored by Zilu Chen
This map shows the geographic impact of Zilu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilu Chen more than expected).
Fields of papers citing papers by Zilu Chen
This network shows the impact of papers produced by Zilu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilu Chen. The network helps show where Zilu Chen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zilu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 14 | |
| 5 | 2023 | 16 | |
| 6 | Naringin Inhibits the Proliferation, Migration, Invasion and Epithelial-to-Mesenchymal Transition of Gastric Cancer Cells via the PI3K/AKT Signaling Pathway. | 2023 | 5 |
| 7 | 2023 | 24 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 23 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 8 | |
| 12 | 2022 | 4 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 56 | |
| 15 | 2021 | 14 | |
| 16 | 2019 | 25 | |
| 17 | Cleavage of GSDME by caspase-3 determines lobaplatin-induced pyroptosis in colon cancer cellsbreakdown → | 2019 | 383 |
| 18 | 2017 | 124 | |
| 19 | 2017 | 1 | |
| 20 | 2017 | 19 |
About Zilu Chen
Zilu Chen is a scholar working on Otorhinolaryngology, Cancer Research and Oncology, having authored 25 papers that have together received 774 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), Fibroblast Growth Factor Research (3 papers), Epigenetics and DNA Methylation (3 papers), Ferroptosis and cancer prognosis (3 papers), Head and Neck Cancer Studies (3 papers), Cancer Mechanisms and Therapy (2 papers), RNA Interference and Gene Delivery (2 papers) and Intestinal and Peritoneal Adhesions (2 papers). The work is most often cited by research in Nephrology (128 citations), Molecular Biology (562 citations) and Immunology (172 citations). Zilu Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Xuejun Sun, Junhui Yu, Jianbao Zheng, Jing Guo, Yunhua Wu, Kai Wang, Shan Li, Jie Qi, Xiaokun Li and Longwei Zhao. Their work appears in journals such as ACS Nano, Scientific Reports and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.